Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polyunsaturated fatty acids modulation of smoking-related epigenetics and pulmonary outcomes.

Genes & nutrition·2026
Same author

Melittin in AllergoOncology: From Honey Bee Venom to Anti-Cancer Therapeutic Innovation-An EAACI Position Paper.

Allergy·2026
Same author

Sustained Reduction in Cardiopulmonary Fitness in Long COVID: A Report from the RECOVER-adult Cohort Study.

JACC. Advances·2026
Same author

The Unusual Suspects.

The New England journal of medicine·2026
Same author

Meaningful outcomes in food allergy immunotherapy: Measuring what counts.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Mast Cells in Acute COVID-19 Patients.

Allergy·2026

Related Experiment Video

Updated: Aug 6, 2025

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.5K

CD300a Regulates Mouse Macrophage Functionality in Allergic Inflammation.

Pier Giorgio Puzzovio1, Bruce D Levy2, Francesca Levi-Schaffer1

  • 1Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

International Archives of Allergy and Immunology
|March 17, 2023
PubMed
Summary
This summary is machine-generated.

The inhibitory receptor CD300a regulates macrophage activation, and its absence exacerbates inflammation. Mast cells also influence macrophage function, potentially explaining delayed allergic inflammation resolution in CD300a-deficient mice.

Keywords:
Allergic inflammationCD300aMacrophagesMast cells

More Related Videos

Depletion and Reconstitution of Macrophages in Mice
08:50

Depletion and Reconstitution of Macrophages in Mice

Published on: August 1, 2012

39.8K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.3K

Related Experiment Videos

Last Updated: Aug 6, 2025

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.5K
Depletion and Reconstitution of Macrophages in Mice
08:50

Depletion and Reconstitution of Macrophages in Mice

Published on: August 1, 2012

39.8K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.3K

Area of Science:

  • Immunology
  • Cell Biology
  • Inflammation Research

Background:

  • CD300a is an inhibitory receptor on leukocytes like mast cells (MCs) and macrophages (MΦ), crucial in allergic inflammation (AI).
  • Previous studies showed CD300a absence in mice leads to increased inflammation and delayed resolution.
  • The precise mechanism behind delayed resolution, particularly involving MΦ, remains unclear.

Purpose of the Study:

  • To investigate the CD300a-dependent functionality of mouse macrophages.
  • To understand how CD300a deficiency impacts MΦ phenotype and function in the context of allergic inflammation.

Main Methods:

  • Purification of MΦ from wild-type (WT) and CD300a-/- mice.
  • Analysis of MΦ phenotype switching using M1-M2 inducers and markers.
  • Assessment of MΦ phagocytic ability using bioparticles.
  • Investigation of MC-MΦ interactions via co-incubation with MC supernatants.

Main Results:

  • Naïve CD300a-/- MΦ showed increased sensitivity to LPS activation.
  • MΦ from CD300a-/- mice with allergic peritonitis exhibited increased Arg1 and IL-6 levels.
  • CD300a absence did not impair MΦ phagocytosis.
  • WT MΦ exposed to MC supernatants showed increased iNOS and decreased Arg1 expression.

Conclusions:

  • The inhibitory receptor CD300a modulates MΦ activation states.
  • CD300a deficiency may enhance the inflammatory state in mice.
  • Mast cell-derived factors can influence MΦ phenotype, contributing to delayed allergic inflammation resolution.